GSSC Fact Sheet: GS ActiveBeta U.S. Small Cap Equity ETF
Share
$84.63
close, Nov 18, 2026
Over the year to Nov 18, 2026, GSSC returned +20.0% in total and charged 0.20% a year.
- 1-year total return
- +20.0%
- IWV +12.0% to Nov 18, 2026
- Expense ratio
- 0.20%
- a year
- Net assets
- $1.0bn
- on Nov 17, 2026
- Net flow, 12 months to Aug 31, 2026
- +$305m
- daily basis to Nov 6, 2026
Growth of $10,000, 1 year
GSSC $12,003 +20.0% · IWV $11,199 +12.0% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month−0.2%
3 months−7.6%
Year to date+12.7%
1 year+20.0%
3 years+55.5%
5 years+32.0%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
10X GENOMICS INC0.49%
CAREDX INC0.41%
ALKERMES PLC0.38%
TRAVERE THERAPEUTICS INC0.38%
ENOVA INTERNATIONAL INC0.37%
ACADIAN ASSET MANAGEMENT INC0.34%
ZETA GLOBAL HOLDINGS CORP0.31%
DAVE INC0.30%
STONEX GROUP INC0.29%
ACADIA PHARMACEUTICALS INC0.28%
GSSC top ten by weight, 3.5% of the fund, of its 1,410 equity positions, from the holdings filed for Aug 31, 2026.
Facts
Equity fund · Tracks the Goldman Sachs ActiveBeta U.S. Small Cap Equity Index · First traded Jun 29, 2017 · Benchmark Russell 3000 Index, measured by IWV, which tracks the same index